Actinium Pharmaceuticals names former CorMedix executive as CFO
- Actinium Pharmaceuticals (ATNM) appointed Matt David, M.D., as chief financial officer to lead its finance, accounting, capital markets and investor relations functions.
- David joins from CorMedix (CRMD), where he most recently served as executive vice president and chief business officer.
- Dr. David brings more than two decades of experience across biopharmaceutical operating leadership, healthcare investment banking and equity research.
More on Actinium Pharmaceuticals
KioskNews shows a cleaned-up reading view extracted from the publisher’s page — the original always lives on their site, not ours.